EcoDrugPlus

Chymase-Like

Ensembl ID : ENSMOCG00000012200
Gene Symbol: LOC101996406
3 Cross references
292 Possible Orthologues:

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSMOCG00000012362
Gene Symbol: F2R
3 Cross references
327 Possible Orthologues:

Coagulation Factor Ii, Thrombin

Ensembl ID : ENSMOCG00000019585
Gene Symbol: F2
3 Cross references
85 Possible Orthologues:

Coagulation Factor Iii, Tissue Factor

Ensembl ID : ENSMOCG00000019703
Gene Symbol: F3
3 Cross references
243 Possible Orthologues:

Coagulation Factor Vii

Ensembl ID : ENSMOCG00000009377
Gene Symbol: F7
3 Cross references
274 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSMOCG00000007866
Gene Symbol: F10
3 Cross references
237 Possible Orthologues:

Coagulation Factor Xi

Ensembl ID : ENSMOCG00000017406
Gene Symbol: LOC101984321
3 Cross references
216 Possible Orthologues:

Coagulation Factor Xii

Ensembl ID : ENSMOCG00000001174
Gene Symbol: F12
3 Cross references
185 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSMOCG00000003461
Gene Symbol: CCDC6
3 Cross references
219 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSMOCG00000018935
Gene Symbol: CSF1R
3 Cross references
206 Possible Orthologues:

Complement C1s

Ensembl ID : ENSMOCG00000019687
Gene Symbol: C1S
2 Cross references
199 Possible Orthologues:

Complement C5-Like

Ensembl ID : ENSMOCG00000013729
Gene Symbol: LOC101985767
3 Cross references
192 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).